Stock AMPLIPHI BIOSCIENCES CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Ampliphi Biosciences Corp Nyse

Equities

US03211P3010

Chart calendar Ampliphi Biosciences Corp

1a4e59c9e520856.jl-9bNtIOKFjWtdSVFBrDYM9YMaXySglkn2h13agPjs.uznqNaIsTPIWYpg0GiYpO8tPOffenkZP1BjRuSSUZFjXHIg2vCNv6k4s4w~60d1b2ae80681e58e0dcec35823772e7

Upcoming events on Ampliphi Biosciences Corp

14/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
13/03/2025 Q4 2024 Earnings Release (Projected)
08/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Ampliphi Biosciences Corp

08/05/2024 01:31 am Q1 2024 Earnings Release
22/03/2024 01:35 am Q4 2023 Earnings Release
28/02/2024 10:30 pm Bacteriophage Therapy Summit
15/11/2023 02:30 am Q3 2023 Earnings Release
04/11/2023 02:30 am North American Cystic Fibrosis Conference (
25/10/2023 06:40 pm Phage Futures: Global Digital Summit
27/09/2023 12:15 am Cantor Global Healthcare Conference
14/09/2023 Annual General Meeting
14/08/2023 04:30 pm Q2 2023 Earnings Release
03/06/2023 02:20 am World Targeting Phage Therapy Conference
12/05/2023 01:35 am Q1 2023 Earnings Release
17/03/2023 01:40 am Q4 2022 Earnings Release
30/11/2022 08:30 pm H.C. Wainwright Investor Conference
16/11/2022 Annual General Meeting
10/11/2022 02:45 am Q3 2022 Earnings Release
12/08/2022 01:35 am Interim 2022 Earnings Release
13/05/2022 01:47 am Q1 2022 Earnings Release
30/03/2022 Extraordinary Shareholders Meeting
18/03/2022 01:35 am FY 2021 Earnings Release
01/03/2022 08:30 pm Chardan Metagenomics and Microbiome Medicines Summit

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,82
0,51
59.85%		4,47
4,46
0.37%		5,51
6,13
-10.11%		4,53
3,87
17.01%
4,54

EBITDA
Million USD		Released
Forecast
Spread 		-18,4
-22,0
16.36%		-20,5
-20,9
2.04%		-22,7
-26,3
13.87%		-36,1
-35,5
-1.56%		-39,9
-42,5
6.08%
-45,6

EBIT
Million USD		Released
Forecast
Spread 		-19,8
-22,0
10.14%		-21,6
-20,5
-5.25%		-23,8
-24,9
4.17%		-36,9
-37,4
1.33%		-40,9
-44,9
8.85%
-45,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-19,5
-21,0
7.28%		-22,2
-21,0
-5.4%		-23,2
-24,2
4.51%		-36,9
-36,6
-0.91%		-69,0
-62,0
-11.39%
-72,4

Net income
Million USD		Released
Forecast
Spread 		-19,5
-21,0
7.28%		-22,2
-21,0
-5.4%		-23,2
-24,2
4.51%		-36,9
-36,6
-0.91%		-69,0
-62,0
-11.39%
-72,4

EPS
USD		Released
Forecast
Spread 		-2,49
-2,01
-24.19%		-1,35
-1,26
-6.93%		-0,96
-1,01
4.95%		-1,08
-1,07
-1.41%		-1,91
-1,71
-12.02%
-1,91

Announcement Date19/03/2018/03/2117/03/2216/03/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,03
1,50
-98%		1,24
0,98
25.55%		1,88
1,11
69.41%		1,34
1,66
-19.37%		1,05
1,67
-37.03%		0,80
1,78
-55.26%		0,98
1,81
-45.84%		1,23
0,95
28.34%		1,53
0,86
77.67%		0,97
1,14
-14.93%
1,14


1,15


1,28


0,00


0,00

EBITDA
Million USD		Released
Forecast
Spread


-8,55





-8,40
-10,0
16.03%		-10,1
-8,90
-13.3%		-11,1
-10,4
-6.88%		-9,40
-11,5
18.25%		-10,1
-11,6
12.8%		-9,29
-11,2
17.09%		-9,91
-10,2
2.83%
-10,9


-11,7


-12,8







EBIT
Million USD		Released
Forecast
Spread 		-9,51
-8,40
-13.21%		-8,78
-6,84
-28.33%		-9,22
-7,15
-28.93%		-8,62
-10,3
15.96%		-10,3
-11,1
6.71%		-11,3
-12,9
12.36%		-9,63
-14,4
32.92%		-10,3
-10,5
1.94%		-9,58
-11,5
16.37%		-10,2
-10,9
6.14%
-11,4


-11,8


-12,1


-10,8


-13,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,79
-8,50
-15.18%		-8,77
-6,57
-33.57%		-9,22
-8,32
-10.7%		-8,61
-10,1
14.96%		-10,3
-9,98
-3.32%		-14,5
-11,5
-25.53%		-3,55
-13,4
73.57%		-31,2
-11,3
-175.6%		-19,8
-12,8
-55.24%		-25,0
-11,2
-123.48%
-16,0


-15,6


-15,8


-12,5


-15,1

Net income
Million USD		Released
Forecast
Spread 		-9,79
-8,50
-15.18%		-8,77
-6,57
-33.57%		-9,22
-8,32
-10.7%		-8,61
-10,1
14.96%		-10,3
-9,98
-3.32%		-14,5
-11,5
-25.53%		-3,55
-13,4
73.57%		-31,2
-11,3
-175.6%		-19,8
-12,8
-55.24%		-25,0
-11,2
-123.48%
-16,0


-15,6


-15,8


-12,5


-15,1

EPS
USD		Released
Forecast
Spread 		-0,68
-0,34
-100%		-0,30
-0,21
-42.86%		-0,26
-0,23
-13.04%		-0,24
-0,28
12.73%		-0,29
-0,28
-3.57%		-0,40
-0,32
-25%		-0,10
-0,38
73.33%		-0,86
-0,31
-177.42%		-0,55
-0,35
-57.14%		-0,69
-0,31
-122.58%
-0,44


-0,42


-0,38


-0,23


-0,20

Announcement Date13/08/2012/05/2211/08/2209/11/2216/03/2311/05/2314/08/2314/11/2321/03/2407/05/24-----

Upcoming sector events for Ampliphi Biosciences Corp

15/07/2024 11:15 am ADDLIFE AB: Q2 2024 Earnings Release
22/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
24/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
24/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
25/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 10:30 am BACHEM HOLDING AG: Q2 2024 Earnings Release
26/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 10:30 am BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Ampliphi Biosciences Corp

30/05/2024 01:31 am IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 04:30 pm CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 10:30 am EVOTEC SE: Q1 2024 Earnings Release
22/05/2024 02:44 am ALVOTECH: Q1 2024 Earnings Release
21/05/2024 04:30 pm EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 11:30 am BIOARCTIC AB: Q1 2024 Earnings Release
16/05/2024 01:35 am CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
15/05/2024 01:35 am KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. ARMP Stock
  4. Stock
  5. Calendar Ampliphi Biosciences Corp